Centre Hospitalier Victor Dupouy Argenteuil
- Address
- lock Available on a paid plan
Hematology and Blood Cancer Research at Centre Hospitalier Victor Dupouy Argenteuil
The site’s Service d’Hématologie is involved in research on hemic and lymphatic diseases, with a focus on Waldenström macroglobulinemia. These studies are designed to evaluate new treatment approaches for patients who have already received prior therapy, with the goal of improving disease control and tolerance.
- Waldenström macroglobulinemia in previously treated patients
- Hemic and lymphatic diseases and treatment response
- Testing a new therapy combination to improve effectiveness and tolerability
This area of research reflects the site’s expertise in blood disorders and supports efforts to expand options for people living with difficult-to-treat hematologic cancers.
Respiratory Infection Studies
Clinical research in respiratory tract diseases and bacterial infections includes studies in critically ill patients with ventilator-associated tracheobronchitis. The main aim is to determine whether an inhaled antibiotic strategy can help prevent worsening of infection and reduce the chance of progression to more serious lung disease.
- Ventilator-associated tracheobronchitis in ICU patients
- Bacterial infections in critically ill adults
- Evaluating whether treatment can lower the risk of progression to ventilator-associated pneumonia
This work addresses an important intensive care challenge by exploring ways to improve infection management and patient outcomes in hospitalized adults.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 7 therapeutic areas and 15 of 28 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 6 by active trials.
- 1Centre Hospitalier De Versailles1active
lock +5 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier Victor Dupouy Argenteuil
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A multicentre, double-blind, randomized controlled trial of inhaled amikacin versus placebo in critically ill patients with ventilator-associated tracheobronchitis (AMIVAT) | Centre Hospitalier Regional Universitaire De Tours | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 28 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Adapalene | 1 | Unknown | 2025-04-29 | 2025-04-29 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.